Plasma Aldosterone Is Independently Associated With the Metabolic Syndrome

Bochud, Murielle, Nussberger, Jürg, Bovet, Pascal, Maillard, Marc R., Elston, Robert C., Paccaud, Fred, Shamlaye, Conrad, Burnier, Michel·2006·Hypertension
DOI 10.1161/01.hyp.0000231338.41548.fc

Cited by (225)

Items 101–200 of 225

  1. Aldosterone and cardiovascular risk
    Bruno Vogt, Michel Burnier · 2009 · Current Hypertension Reports
  2. The metabolic syndrome in primary aldosteronism
    Francesco Fallo, Giovanni Federspil, Franco Veglio, Paolo Mulatero · 2007 · Current Hypertension Reports
  3. The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex – a multicenter-study of 3566 Caucasian and Asian subjects
    Ariadni Spyroglou, Laura Handgriff, Lisa Müller, Paul Schwarzlmueller, Mirko Parasiliti‐Caprino, Carmina Teresa Fuß, Hana Remde, Anna Hirsch, Samuel Matthew O’Toole, Moe Thuzar et al. · 2022 · European Journal of Endocrinology
  4. Role of Mineralocorticoid Receptors in Obstructive Sleep Apnea and Metabolic Syndrome
    Badhma Valaiyapathi, David A. Calhoun · 2018 · Current Hypertension Reports
  5. MECHANISMS IN ENDOCRINOLOGY: Brown adipose tissue in humans: regulation and metabolic significance
    Moe Thuzar, Ken K. Y. Ho · 2016 · European Journal of Endocrinology
  6. Genes implicated in insulin resistance are down-regulated in primary aldosteronism patients
    Tracy Ann Williams, Silvia Monticone, Riccardo Urbanet, Chiara Bertello, Giuseppe Giraudo, Roberto Vettor, Francesco Fallo, Franco Veglio, Paolo Mulatero · 2012 · Molecular and Cellular Endocrinology
  7. Aldosterone biosynthesis in the human adrenal cortex and associated disorders
    Yasuhiro Nakamura, Yuto Yamazaki, Sachiko Konosu‐Fukaya, Kazue Ise, Fumitoshi Satoh, Hironobu Sasano · 2015 · The Journal of Steroid Biochemistry and Molecular Biology
  8. Renal aspirin: will all patients with chronic kidney disease one day take spironolactone?
    Andrew S. Bomback, Abhijit V. Kshirsagar, Philip J. Klemmer · 2008 · Nature Reviews Nephrology
  9. Renal manifestations of metabolic syndrome in type 2 diabetes
    Ko Hanai, Tetsuya Babazono, Yasuhiko Iwamoto · 2007 · Diabetes Research and Clinical Practice
  10. The differences of serum lipid profiles between primary aldosteronism and essential hypertension: a meta-analysis and systematic review
    Worapaka Manosroi, Pitchaporn Phudphong, Pichitchai Atthakomol, Mattabhorn Phimphilai · 2022 · BMC Endocrine Disorders
  11. Adipocyte Mineralocorticoid Receptor
    Marco Infante, Andrea Armani, Vincenzo Marzolla, Andrea Fabbri, Massimiliano Caprio · 2018 · Vitamins and hormones
  12. Obesity, metabolic syndrome, and inflammation: An update for anaesthetists caring for patients with obesity
    Victoria A. Eley, Moe Thuzar, Séverine Navarro, Benjamin Rees Dodd, André A.J. van Zundert · 2021 · Anaesthesia Critical Care & Pain Medicine
  13. Racial Differences in Kidney Function Among Individuals With Obesity and Metabolic Syndrome: Results From the Kidney Early Evaluation Program (KEEP)
    Andrew S. Bomback, Abhijit V. Kshirsagar, Adam T. Whaley‐Connell, Shu‐Cheng Chen, Suying Li, Philip J. Klemmer, Peter Andrew McCullough, George L. Bakris · 2010 · American Journal of Kidney Diseases
  14. Cardiovascular and metabolic characters of KCNJ5 somatic mutations in primary aldosteronism
    Yi‐Yao Chang, Bo‐Ching Lee, Zheng‐Wei Chen, Cheng‐Hsuan Tsai, Chin‐Chen Chang, Che‐Wei Liao, Chien‐Ting Pan, Kang‐Yung Peng, Chia‐Hung Chou, Ching‐Chu Lu et al. · 2023 · Frontiers in Endocrinology
  15. Iron restriction inhibits renal injury in aldosterone/salt-induced hypertensive mice
    Hisashi Sawada, Yoshiro Naito, Makiko Oboshi, Toshihiro Iwasaku, Yoshitaka Okuhara, Daisuke Morisawa, Akiyo Eguchi, Shinichi Hirotani, Tohru Masuyama · 2015 · Hypertension Research
  16. Activation of Mineralocorticoid Receptor in Salt-Sensitive Hypertension
    Nobuhiro Ayuzawa, Toshiro Fujita · 2015 · Current Hypertension Reports
  17. Modified high-density lipoprotein modulates aldosterone release through scavenger receptors via extra cellular signal-regulated kinase and Janus kinase-dependent pathways
    Sarama Saha, Juergen Graessler, Peter E. H. Schwarz, Claudia Goettsch, Stefan Richard Bornstein, Steffi Kopprasch · 2012 · Molecular and Cellular Biochemistry
  18. ARMC5 Variants and Risk of Hypertension in Blacks: MH‐GRID Study
    Mihail F Zilbermint, Amadou Gaye, Annabel S. Berthon, Fady Hannah‐Shmouni, Fabio Rueda Faucz, Maya Beth Lodish, Adam R. Davis, Gary H. Gibbons, Constantine A. Stratakis · 2019 · Journal of the American Heart Association
  19. Adrenal steroids and the metabolic syndrome
    Stephen P. Thomson, Craig S. Stump, L. Romayne Kurukulasuriya, James R. Sowers · 2007 · Current Hypertension Reports
  20. Obesity-Associated Heart Failure as a Theoretical Target for Treatment With Mineralocorticoid Receptor Antagonists
    Milton Packer · 2018 · JAMA Cardiology
  21. Association of Aldosterone, Plasma Renin Activity (PRA) and Superoxide Dismutase (SOD) with Inflammation and Insulin Resistance in Adult Men with Central Obesity
    Hera Yuliana Intantri, Andi Wijaya, Ilhamjaya Patellongi · 2011 · The Indonesian Biomedical Journal
  22. Aldosterone and Metabolic Dysfunction
    Eduardo Pimenta, David A. Calhoun · 2009 · Hypertension
  23. The emerging role of leptin in obesity-associated cardiac fibrosis: evidence and mechanism
    Yukang Mao, Kun Zhao, Peng Li, Yanhui Sheng · 2022 · Molecular and Cellular Biochemistry
  24. Aldosterone and Hypertension in the Cardiometabolic Syndrome
    Sameer N. Stas, Adam T. Whaley‐Connell, James R. Sowers · 2008 · Journal of Clinical Hypertension
  25. Effect of Selective Mineralocorticoid Receptor Blockade on Flow-Mediated Dilation and Insulin Resistance in Older Adults with Metabolic Syndrome
    Moon‐Hyon Hwang, Jeung‐Ki Yoo, Meredith J. Luttrell, Thomas H. Meade, Mark W. English, Demetra D. Christou · 2015 · Metabolic Syndrome and Related Disorders
  26. Aldosterone, hypertension, and beyond.
    Shiva Samavat, Pedram Ahmadpoor, Fariba Samadian · 2011 · Iranian Journal of Kidney Diseases
  27. Effect of low dose mineralocorticoid receptor antagonist eplerenone on glucose and lipid metabolism in healthy adult males
    Alexander W. Krug, Lissy Stelzner, Ajay Dhanwada Rao, Andrew H. Lichtman, Gordon H. Williams, Gail Kurr Adler · 2012 · Metabolism
  28. Aldosterone and Risk for Insulin Resistance
    Adam T. Whaley‐Connell, James R. Sowers · 2011 · Hypertension
  29. Lipid Profiles in Primary Aldosteronism Compared with Essential Hypertension: Propensity-Score Matching Study
    Sun Joon Moon, Han Na Jang, Jung Hee Kim, Min Kyong Moon · 2021 · Endocrinology and Metabolism
  30. Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension
    Thierry H. Le Jemtel, William Richardson, Rohan Samson, Abhishek Jaiswal, Suzanne Oparil · 2017 · Current Hypertension Reports
  31. Resistant hypertension: Renal denervation or intensified medical treatment?
    Alberto Morganti, Giuseppe Mancia · 2017 · European Journal of Internal Medicine
  32. Higher plasma aldosterone is associated with increased risk of cardiovascular events in hypertensive patients with suspected OSA: UROSAH data
    Lin Gan, Nanfang Li, Mulalibieke Heizhati, Mengyue Lin, Qing Zhu, Xiaoguang Yao, Ting Wu, Menghui Wang, Qin Luo, Delian Zhang et al. · 2022 · Frontiers in Endocrinology
  33. Unilateral adrenalectomy improves urinary protein excretion but does not abolish its relationship to sodium excretion in patients with aldosterone-producing adenoma
    Eduardo Pimenta, Richard D. Gordon, Ashraf Hashim Ahmed, Diane Cowley, Dianne Robson, Cynthia Kogovsek, Michael Stowasser · 2010 · Journal of Human Hypertension
  34. Relationships between metabolic syndrome and left ventricular mass in hypertensive patients: does sex matter?
    Giuseppe Mulè, Paola Cusimano, Emilio Nardi, Santina Cottone, Claudia Geraci, Alessandro Palermo, M. Costanzo, Anna Carola Foraci, Giovanni Cerasola · 2008 · Journal of Human Hypertension
  35. Effect of Carperitide on Plasma Adiponectin Levels in Acute Decompensated Heart Failure Patients With Diabetes Mellitus
    Masayuki Yamaji, Takayoshi Tsutamoto, Toshinari Tanaka, Chiho Kawahara, Keizo Nishiyama, Takashi Yamamoto, Masanori Fujii, Minoru Horie · 2009 · Circulation Journal
  36. Bariatric Surgery Induces a Differential Effect on Plasma Aldosterone in Comparison to Dietary Advice Alone
    Maxime Berney, Nima Vakilzadeh, Marc P Maillard, Mohamed Faouzi, Eric Grouzmann, Olivier Bonny, Lucie Favre, Grégoire Wuerzner · 2021 · Frontiers in Endocrinology
  37. Aldosterone to Active Renin Ratio Is Associated With Nocturnal Blood Pressure in Obese and Treated Hypertensive Patients: The Styrian Hypertension Study
    Martin Robert Grübler, Katharina Kienreich, Martin Gaksch, Nicolas Verheyen, Astrid Fahrleitner‐Pammer, Johannes Schmid, Jana Grogorenz, Klemens Ablasser, Burkert Mathias Pieske, Andreas Tomaschitz et al. · 2014 · Journal of Clinical Hypertension
  38. Vascular Dysfunction and Insulin Resistance in Aging
    Agnieszka Baranowska-Bik, Wojciech Bik · 2018 · Current Vascular Pharmacology
  39. Plasma Renin Activity and Resting Heart Rate in a Population of Community-Dwelling Japanese: The Tanushimaru Study
    Hisashi Adachi, Mika Enomoto, Ako Fukami, Eita Kumagai, Sachiko Nakamura, Ayako Yoshimura, Aya Obuchi, Kensuke Hori, Yume Nohara, Erika Nakao et al. · 2014 · American Journal of Hypertension
  40. Factors correlated with plasma renin activity in general Japanese population
    Hiroshi Abiko, Tsuneo Konta, Zhimei Hao, Satoshi Takasaki, Kazuko Suzuki, Kazunobu Ichikawa, Ami Ikeda, Yoko Shibata, Yasuchika Takeishi, Sumio Kawata et al. · 2008 · Clinical and Experimental Nephrology
  41. Hipertensión arterial : diagnóstico, tratamiento y control
    Joaquín Sellén Crombet · 2008
  42. The role of aldosterone in cardiovascular disease in people with diabetes and hypertension: An update
    Guido Lastra‐González, Camila Manrique‐Acevedo, James R. Sowers · 2008 · Current Diabetes Reports
  43. Changes of aldosterone levels in patients with type 2 diabetes complicated by moderate to severe obstructive sleep apnea–hypopnea syndrome before and after treatment with continuous positive airway pressure
    Jie Zhang, Lin Tian, Lixin Guo · 2019 · Journal of International Medical Research
  44. Aldosterone: a cardiometabolic risk hormone?
    Patrícia Feliciano Pereira, Sílvia Eloiza Priore, Josefina Bressan · 2014 · PubMed
  45. Antenatal Betamethasone Depresses Maternal and Fetal Aldosterone Levels
    Julie M. Kessel, Jacqueline M. Cale, E. Verbrick, C. Richard Parker, D P Carlton, Ian M. Bird · 2008 · Reproductive Sciences
  46. Higher Screening Aldosterone to Renin Ratio in Primary Aldosteronism Patients with Diabetes Mellitus
    Chia‐Hui Chang, Ya‐Hui Hu, Kuo‐How Huang, Yen‐Hung Lin, Yao‐Chou Tsai, Che‐Hsiung Wu, Shao‐Yu Yang, Chin‐Chen Chang, Ching‐Chu Lu, Kwan‐Dun Wu et al. · 2018 · Journal of Clinical Medicine
  47. Mineralocorticoid receptor antagonists for the treatment of hypertension and the metabolic syndrome
    Pitt, Bertram · 2015 · Hypertension
  48. Post-treatment renin status and cardiovascular, renal, and mortality outcomes in medically treated primary aldosteronism: a systematic review and meta-analysis
    Sho Katsuragawa, Minh V Le, Peter J. Fuller, Jun Jie Yang · 2025 · The Lancet Diabetes & Endocrinology
  49. Influence of CYP11B2 Gene Polymorphism on the Prevalence of Hypertension and the Blood Pressure in Japanese Men: Interaction with Dietary Salt Intake
    Yixuan Song, Koichi Miyaki, Jungo Araki, Ling Zhang, Yoshimitsu Takahashi, Takeo Nakayama, Masaaki Muramatsu · 2008 · Lifestyle Genomics
  50. Aldosterone and CKD in metabolic syndrome
    Toshiro Fujita · 2008 · Current Hypertension Reports
  51. Multifactorial intervention in metabolic syndrome targeting at prevention of chronic kidney disease ready for prime time?
    Panagiotis G. Korantzopoulos, Moses Elisaf, Haralampos J. Milionis · 2007 · Nephrology Dialysis Transplantation
  52. Reviving the use of aldosterone inhibitors in treating hypertension in obesity
    Anne-Cécile Huby, Eric J. Belin de Chantemèle · 2015 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  53. The mineralocorticoid receptor: a new player controlling energy homeostasis
    Emmanuelle Kuhn, Marc Lombès · 2013 · Hormone Molecular Biology and Clinical Investigation
  54. Effects of green tea on blood pressure and hypertension-induced cardiovascular damage in spontaneously hypertensive rat
    Yue‐Rong Liang, Shicheng Ma, Xianyang Luo, Jingyi Xu, Mingyan Wu, Yi-Wen Luo, Xin‐Qiang Zheng, Jian-Liang Lu · 2011 · Food Science and Biotechnology
  55. Aging and Remodeling of the RAS and RAAS and Related Pathways: Implications for Heart Failure Therapy
    Bodh I. Jugdutt · 2014 · Springer eBooks
  56. Aldosterone is not Involved in the Ventricular Remodeling Process Induced by Tobacco Smoke Exposure
    Dos Santos, Bruna Franco Nogueira, Bruna Paola Murino Rafacho, Paula S. Azevedo, Bertha Furlan Polegato, Fernanda Chiuso‐Minicucci, Camila Bonomo, Meliza Goi Roscani, Sofia Fernanda Gonçalves Zorzella-Pezavento, Suzana Érico Tanni et al. · 2012 · Cellular Physiology and Biochemistry
  57. Meta‐analysis of blood parameters related to lipid and glucose metabolism between two subtypes of primary aldosteronism
    Qiu‐Gen Zhu, Feng Zhu · 2022 · Journal of Clinical Hypertension
  58. Fatty acids as a direct regulator of aldosterone hypersecretion
    Guoyu Ling, Jonathan Bruno, Stewart Gary Albert, Sandeep Dhindsa · 2022 · Molecular and Cellular Endocrinology
  59. Management of the Hypertensive Child
    Demetrius Ellis · 2009 · Springer eBooks
  60. Delayed diagnosis of primary aldosteronism in patients with autosomal dominant polycystic kidney diseases
    Chih‐Chin Kao, Vin‐Cent Wu, Chin-Chi Kuo, Yen‐Hung Lin, Ya-Hui Hu, Yao‐Chou Tsai, Che‐Hsiung Wu, Kwan‐Dun Wu, TAIPAI study group · 2012 · Journal of the Renin-Angiotensin-Aldosterone System
  61. Comparison of Clinical Features between Primary Aldosteronism and Essential Hypertension in Chinese Patients: A Case-Control Study
    Xiaoyu Huang, Shuang Yu, Huangmeng Xiao, Ling Pei, Yan Chen, Wenzhan Chen, Yanbing Li, Haipeng Xiao, Xiaopei Cao · 2021 · International Journal of Endocrinology
  62. Interactions between CKD and MetS and the Development of CVD
    Ken‐ichi Aihara, Masaki Mogi, Rei Shibata, David Bishop‐Bailey, Xin L. Ma · 2011 · Cardiology Research and Practice
  63. Primary aldosteronism: A consequence of sugar and western Diet?
    Kai M. Hahn, Bernardo Rodríguez‐Iturbe, Bernd Winterberg, Laura Gabriela Sánchez‐Lozada, Mehmet Kanbay, Miguel Angel Lanaspa, Richard J. Johnson · 2022 · Medical Hypotheses
  64. The mineralocorticoid system, cardiometabolic health and its interplay with adipose tissue
    Moe Thuzar, M. Abdul Halim, Michael Stowasser · 2024 · Journal of Endocrinology
  65. Rising Prevalence of Obesity and Primary Hyperaldosteronism: Co-incidence or Connected Circumstances Leading to Hypertension? A Narrative Review
    Shweta Bansal, Houry V. Puzantian, Raymond R. Townsend · 2024 · Journal of General Internal Medicine
  66. Clinical Characteristics of Target Organ Damage in Primary Aldosteronism with or without Metabolic Syndrome
    Xiaona Bu, Fang Sun, Hexuan Zhang, Xiaoli Liu, Zhigang Zhao, Hongbo He, Yingsha Li, Zhencheng Yan, Zhiming Zhu · 2022 · Journal of Diabetes Research
  67. Activation of angiotensin-converting enzyme 2 ameliorates metabolic syndrome-induced renal damage in rats by renal TLR4 and nuclear transcription factor κB downregulation
    Heba Fathy El-Domiaty, Eman M. Sweed, Mona Abdelhamid Mohammed Kora, Nader G. Zaki, Suzan A Khodir · 2022 · Frontiers in Medicine
  68. Role of Aldosterone in Insulin Resistance: Fact of Fantasy
    Leonardo Alberto Sechi, GianLuca Colussi · 2015 · Endocrinology & Metabolic Syndrome
  69. Eplerenone–A novel Mineralocorticoid receptor antagonist for the clinical application
    Nannan Wu, Yuan-Yuan Zhang, Dong Zhao · 2022 · Environmental Disease
  70. Epithelial sodium channels: contributions to the regulation of vascular function and blood pressure
    Guanghong Jia, Adam T. Whaley‐Connell, Michael A. Hill · 2025 · American Journal of Physiology-Heart and Circulatory Physiology
  71. Targeting Heart Disease in Cardiovascular–Kidney–Metabolic Syndrome: A Review of Novel Therapeutic Approaches with Prognostic and Quality-of-Life Impact
    Adrian G. Florescu, Sânziana A. Pucerea, Mariana Floria, Emilia Rusu, Elena Cuiban, Mariana Jinga, Ruxandra Drăgoi Galrinho, Silviu Marcel Stanciu · 2025 · Romanian Journal of Military Medicine
  72. Combined effect of esaxerenone and dapagliflozin on aldosterone-mediated sodium reabsorption and potassium excretion
    Motonobu Nakamura, Nobuhiko Satoh, Tomohito Mizuno, Mayuko Takagi, Shoko Horita, Masaomi Nangaku · 2025 · Frontiers in Physiology
  73. Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review
    Xurong Mai, Mitsuhiro Kometani, Takashi Yoneda · 2022 · International Journal of Molecular Sciences
  74. A Single Initiating Cause of Hypertension; Potential for Primary Prevention
    Mohinder P. Sambhi · 2014 · Journal of Hypertension Open Access
  75. Mechanisms for Obesity Related Kidney Disease
    Praveen Murlidharan, Sreelekshmi Kamaladevan, Satish Balan, Chandrasekharan C. Kartha · 2020 · Springer eBooks
  76. Phospholipase D mediates very low-density lipoprotein-induced aldosterone production, in part, via lipin-1
    Shinjini C. Spaulding, Vivek Choudhary, Wendy Bollinger Bollag · 2023 · Journal of Molecular Endocrinology
  77. Integrative Analysis of Metabolomic and Transcriptomic Data Reveals Metabolic Signatures and Major Metabolic Pathways in Primary Aldosteronism
    Xiaomei Lai, Tingting Yang, Chaoping Wei, Shuangbei Zhu, Jianling Li · 2025 · Endocrine Metabolic & Immune Disorders - Drug Targets
  78. Impact of Mineralocorticoid Receptor and Angiotensin II Type 1 Receptor Antagonism on Blood Pressure Regulation in Obese Zucker Rats: Role of Sex Differences
    Jussara Marcia do Carmo, Alexandre A. da Silva, John Edward Hall · 2020 · American Journal of Hypertension
  79. Mineralocorticoid Receptor in Calcium Handling of Vascular Smooth Muscle Cells
    Rogelio Salazar-Enciso, Nohemí Camacho‐Concha, Thássio Mesquita, Débora Falcón, Jean‐Pierre Bénitah, Ana Maria Gomez, Angélica Rueda · 2018 · InTech eBooks
  80. Insights into causal associations between type 2 diabetes and common human diseases: a phenotype-wide bi-directional Mendelian randomization analysis
    Wenxi Sun, Hongbao Cao, Dongming Liu, Ancha V. Baranova, Xiaobin Zhang, Fuquan Zhang · 2025 · Nutrition Metabolism and Cardiovascular Diseases
  81. Eligibility for Statin Therapy According to New Cholesterol Guidelines on Primary Aldosteronism
    Jui‐Hsiang Lin, Wei-Jie Wang, Vin‐Cent Wu, Kwan‐Dun Wu · 2015 · The Journal of Clinical Endocrinology & Metabolism
  82. Diuretic‐Induced Potassium Depletion and Glucose Intolerance Are Not Related to Hyperactivity of the Renin‐Angiotensin‐Aldosterone System in Hypertensive Patients With the Metabolic Syndrome
    Douglas Eugenio Barbieri, Fernando Flexa Ribeiro‐Filho, Artur Beltrame Ribeiro, Maria Teresa Zanella · 2009 · Journal of Clinical Hypertension
  83. Treatment of Resistant Hypertension. Which Additional Antihypertensive Drugs?
    Michel Burnier, Antoinette Pechère Bertschi, Grégoire Wuerzner · 2013 · Springer eBooks
  84. Torasemide: additional benefits for postmenopausal women with arterial hypertension
    O N Tkacheva, Н. К. Рунихина, Н. В. Шарашкина · 2013 · Systemic Hypertension
  85. The Renin-Angiotensin-Aldosterone System and Metabolic Syndrome
    Michel Burnier · 2006 · Journal of the Renin-Angiotensin-Aldosterone System
  86. Autosomal dominant polycystic kidney disease and hypertension masquerading primary aldosteronism
    P Mital, K Abhijit, G Shishir · 2017 · Indian Journal of Nephrology
  87. Diurnal Urinary Aldosterone Excretion and Potassium Intake During Pregnancy Are Associated With High Normal Blood Pressure in Early Childhood
    Hajir Al-Jorani, Richard Christian Jensen, Tina Kold Jensen, Henrik Thybo Christesen, Jan Stener Jørgensen, Lucas Bacmeister, Ralf Dechend, Dorte Glintborg, Boye Lagerbon Jensen, Marianne Andersen · 2025 · Journal of the American Heart Association
  88. Unveiling the role of aldosterone in metabolic dysfunction–associated steatotic liver disease
    Anna Hernández‐Rubio, María Teresa Julián, Elena Valassi, Núria Alonso, Manel Puig‐Domingo · 2026 · Reviews in Endocrine and Metabolic Disorders
  89. Increased aldosterone in patients with metabolic syndrome; an additional risk factor
    Mohamed H. Abdou, Mohamed Sherif Abd El Gawad, Sahar Mohamed · 2013 · journal of Diabetes Research and Clinical Metabolism
  90. Metabolic Syndrome among Ischaemic Stroke Patients in Ghana: The Possible Role of Renin and Aldosterone
    Francis Agyemang Yeboah, Bernard Cudjoe Nkum, Bright Amankwaa, Benjamin Eghan, Emmanuel Acheampong, Paul Nsiah, Perditer Okyere, Lawrence Owusu, Emmanuella Nsenbah Batu, Enoch Odame Anto · 2017 · OALib
  91. Obesity in Hypertension
    Xavier Pi-Sunyer, Panagiotis Kokkoris · 2007 · Elsevier eBooks
  92. The Relationship between Obesity, Insulin Resistance and Aldosterone Levels
    Tânia Longo Mazzuco · 2018 · Current Research in Diabetes & Obesity Journal
  93. Identification of latent disorders of carbohydrate metabolism in conjunction with neurohormonal status in hospitalized patients with chronic heart failure of ischemic etiology
    А М Норузбаева, B. T. Kurmanbekova, G. Osmankulova · 2019 · CARDIOVASCULAR THERAPY AND PREVENTION
  94. Management of the Hypertensive Child
    Demetrius Ellis, Yosuke Miyashita · 2015 · Springer eBooks
  95. Corticosteroid Receptors, Their Chaperones and Cochaperones: How Do They Modulate Adipogenesis?
    Judith Toneatto, Nancy L. Charó, Agostina Naselli, Melina Muñoz-Bernart, Antonella Lombardi, Graciela Piwien‐Pilipuk · 2014 · Nuclear Receptor Research
  96. Diabetes in Hyperaldosteronism
    Valentina Laura Crudo, Paolo Mulatero, Silvia Monticone, Franco Veglio · 2014 · Frontiers in diabetes
  97. Entwicklung von Teststrategien zur selektiven Hemmung von Enzymen der adrenalen Steroidsynthese unter besonderer Berücksichtigung von Speziesunterschieden
    Sabrina Rau · 2014 · Publications of the UdS (Saarland University)
  98. Context-dependent effects of the renin-angiotensin-aldosterone system on blood pressure in a group of African ancestry
    Leon J Scott · 2012 · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
  99. Influence of antihypertensive therapy, sodium intake and the concentration of potassium in plasma on concentration of aldosterone and plasma renin activity
    Tijana Lalić · 2013 · Medicinski glasnik Specijalna bolnica za bolesti stitaste zlezde i bolesti metabolizma Zlatibor
  100. 3) Aldosterone and Adult Disease
    Miki Nagase, Toshiro Fujita · 2008 · Nihon Naika Gakkai Zasshi